Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Liabilities and Shareholders Equity (2017 - 2025)

Selectis Health's Liabilities and Shareholders Equity history spans 13 years, with the latest figure at $32.6 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $32.6 million for Q4 2025, down 2.6% from a year ago — trailing twelve months through Dec 2025 was $134.0 million (down 6.71% YoY), and the annual figure for FY2025 was $32.6 million, down 2.6%.
  • Liabilities and Shareholders Equity for Q4 2025 was $32.6 million at Selectis Health, down from $33.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $48.7 million in Q1 2023 to a low of $32.6 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $42.4 million (2022), against an average of $41.1 million.
  • The sharpest move saw Liabilities and Shareholders Equity grew 11.73% in 2021, then fell 21.75% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $46.9 million in 2021, then dropped by 9.45% to $42.5 million in 2022, then fell by 4.28% to $40.7 million in 2023, then dropped by 17.76% to $33.4 million in 2024, then dropped by 2.6% to $32.6 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $32.6 million, $33.3 million, and $33.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.